Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Kedudukan dalam Saham #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Harga Saham
$154.04
Modal Pasaran
$2.21B
Perubahan (1 hari)
-0.19%
Perubahan (1 tahun)
172.88%
Negara
US
Perdagangan Palvella Therapeutics, Inc. (PVLA)

Kategori

Sejarah harga saham bagi Palvella Therapeutics, Inc. (PVLA)
Harga penutupan tertinggi: $151.69 pada 2026-08-01

Harga penutupan terendah: $13.11 pada 2024-12-01
Sejarah harga saham Palvella Therapeutics, Inc. dari 2024 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$547.65 40.75%
US
$1.06K 49.04%
NL
$122.63 -12.65%
AU
$143.63 472.23%
US
$765.25 7.19%
CH